Inventor · disambiguated record
Gareth Charles Glyndwr Davies
Also filed as: DAVIES GARETH · DAVIES GARETH CHARLES · DAVIES GARETH CHARLES GLYNDWR
7 granted patents·4 pending applications·14 citations·filing 2011–2023
79Inventor score
Top patents by PatentIndex Score
11 records- 0192US11807680B2Gremlin-1 crystal structure and inhibitory antibodyUCB Biopharma SRL·Filed 2021·Granted Nov 7, 2023·3 cites·4 claims
- 0289US10947304B2Gremlin-1 antibodyUCB Biopharma SRL·Filed 2017·Granted Mar 16, 2021·6 cites·12 claims
- 0387US11524997B2Gremlin-1 inhibitor for the treatment of a bone fracture or bone defectUCB Biopharma SRL·Filed 2019·Granted Dec 13, 2022·4 cites·12 claims
- 0482US12473355B2Gremlin-1 crystal structure and inhibitory antibodyUCB Biopharma SRL·Filed 2023·Granted Nov 18, 2025·0 cites·17 claims
- 0581US11795225B2Therapeutic binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Oct 24, 2023·1 cites·38 claims
- 0672US12240896B2Gremlin-1 inhibitor for the treatment of a bone fracture or bone defectUCB Biopharma SRL·Filed 2022·Granted Mar 4, 2025·0 cites·4 claims
- 0770US2024239894A1Therapeutic binding moleculesMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 0861US2025243267A1Combination of a gremlin-1 antagonist with a cytidine analogue or deoxycytidine analogueUCB Biopharma SRL·Filed 2023·Application pending·0 cites
- 0955US2025228826A1Combination of a gremlin-1 antagonist with an inhibitor of ras-raf-mek-erk signallingUCB Biopharma SRL·Filed 2023·Application pending·0 cites
- 1053US12162934B2Gremlin-1 antagonist for the prevention and treatment of cancerUCB Biopharma SRL·Filed 2019·Granted Dec 10, 2024·0 cites·29 claims
- 1137US2011281852A1Pharmaceutical compositions containing berberine for treatment or prevention of weight gain and obesity associated with anti-psychotic drugsDAVIES GARETH·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gareth Charles Glyndwr Davies files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →